Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bode

Showing results (391-400 of 756) with videos related to

Pageof 76
Sort By:
Blood Purification|August 31, 2006
No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patientsMarta Kalousová, Jan T Kielstein, Magdaléna Hodková, et al.
International Journal of Clinical Practice|April 24, 2014
Combined DaT imaging and olfactory testing for differentiating parkinsonian disordersP Borghammer, K Knudsen, K Østergaard, et al.
Cellular & Molecular Immunology|April 8, 2015
AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancersZhi Duan, Hui Zheng, Haidan Liu, et al.
Physical Review Letters|September 4, 2008
Atomic-scale spin spiral with a unique rotational sense: Mn monolayer on W(001)P Ferriani, K von Bergmann, E Y Vedmedenko, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2010
RSK2 mediates NF-{kappa}B activity through the phosphorylation of IkappaBalpha in the TNF-R1 pathwayCong Peng, Yong-Yeon Cho, Feng Zhu, et al.
Cancer Research|January 22, 2009
Transient receptor potential type vanilloid 1 suppresses skin carcinogenesisAnn M Bode, Yong-Yeon Cho, Duo Zheng, et al.
Journal of the American Society of Nephrology : JASN|March 12, 1999
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic diseaseJ T Kielstein, R H Böger, S M Bode-Böger, et al.
Cancer Research|April 3, 2008
Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformationHong-Gyum Kim, Ki Won Lee, Yong-Yeon Cho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2011
Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney diseaseJan T Kielstein, Mayuren Suntharalingam, Ronny Perthel, et al.
FEBS Letters|June 17, 2009
A selective small-molecule inhibitor of c-Jun N-terminal kinase 1Ke Yao, Yong-Yeon Cho, Ann M Bode, et al.
Pageof 76

Showing results (391-400 of 756) with videos related to

Sort By:
Pageof 76
Blood Purification|August 31, 2006
No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patientsMarta Kalousová, Jan T Kielstein, Magdaléna Hodková, et al.
International Journal of Clinical Practice|April 24, 2014
Combined DaT imaging and olfactory testing for differentiating parkinsonian disordersP Borghammer, K Knudsen, K Østergaard, et al.
Cellular & Molecular Immunology|April 8, 2015
AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancersZhi Duan, Hui Zheng, Haidan Liu, et al.
Physical Review Letters|September 4, 2008
Atomic-scale spin spiral with a unique rotational sense: Mn monolayer on W(001)P Ferriani, K von Bergmann, E Y Vedmedenko, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2010
RSK2 mediates NF-{kappa}B activity through the phosphorylation of IkappaBalpha in the TNF-R1 pathwayCong Peng, Yong-Yeon Cho, Feng Zhu, et al.
Cancer Research|January 22, 2009
Transient receptor potential type vanilloid 1 suppresses skin carcinogenesisAnn M Bode, Yong-Yeon Cho, Duo Zheng, et al.
Journal of the American Society of Nephrology : JASN|March 12, 1999
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic diseaseJ T Kielstein, R H Böger, S M Bode-Böger, et al.
Cancer Research|April 3, 2008
Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformationHong-Gyum Kim, Ki Won Lee, Yong-Yeon Cho, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 2, 2011
Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney diseaseJan T Kielstein, Mayuren Suntharalingam, Ronny Perthel, et al.
FEBS Letters|June 17, 2009
A selective small-molecule inhibitor of c-Jun N-terminal kinase 1Ke Yao, Yong-Yeon Cho, Ann M Bode, et al.
Pageof 76